CA 19-9 Response as an Early Indicator of the Effectiveness of Gemcitabine in Patients with Advanced Pancreatic Cancer

  • Yousuke Nakai, Takao Kawabe, Hiroyuki Isayama, Takashi Sasaki, Hiroshi Yagioka, Yoko Yashima, Hirofumi Kogure, Toshihiko Arizumi, Osamu Togawa, Yukiko Ito, Saburo Matsubara, Kenji Hirano, Naoki Sasahira, Takeshi Tsujino, Minoru Tada, Masao Omata
  • Oncology, January 2008, Karger Publishers
  • DOI: 10.1159/000155213

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1159/000155213

The following have contributed to this page: Dr Yousuke Nakai

In partnership with: